Quantum closes final C$2.42M tranche of C$5M total financing

Quantum BioPharma closed the final tranche of the offering announced on December 5, 2024 has amended on January 20, 2025, and based on the better terms announced on March 7, 2025. The Company issued 2,420 Debenture Units for C$2,420,000 as part of this Final Tranche bringing the total amount raised to C$5 million. The Company will use the proceeds to advance the research and development of its innovative drug candidates, advancing commercialization and monetization of certain assets, and for general working capital purposes. Management now believes there is enough cash to execute on these advances until at least the first quarter of 2027. In addition, the Company has begun development of a formulation for rekvry, an alcohol misuse treatment for emergency and hospital settings. The Company believes that rekvry fulfills an unmet need in healthcare settings, reducing the costs and burden on healthcare resources and staff.